Poster Presentation 31st Lorne Cancer Conference 2019

The NUP98-HOXD13 fusion oncogene induces thymocyte self-renewal via Lmo2/Lyl1 (#373)

Benjamin J Shields 1 , Christopher I Slape 2 , Ngoc Vo 1 , Jacob T Jackson 1 , Adriana Pliego 2 , Hansi Ranasinghe 2 , Wei Shi 3 4 , David Curtis 1 5 , Matthew McCormack 1
  1. Australian Centre for Blood Diseases, Monash University, Prahran, Victoria, Australia
  2. Diamantina Institute, University of Queensland, Brisbane, Queensland, Australia
  3. The Walter & Eliza Hall Institute for Medical Research, Parkville, Victoria, Australia
  4. Department of Computing and Information Systems, The University of Melbourne, Parkville, Victoria, Australia
  5. Clinical Haematology, Alfred Hospital, Melbourne, Victoria, Australia

T-cell Acute Lymphoblastic Leukaemias (T-ALL) cases include subfamilies that overexpress the TAL1/LMO, TLX1/3 and HOXA transcription factor oncogenes. Whilst it has been shown that TAL1/LMO transcription factors induce self-renewal of thymocytes, whether this is true for other transcription factor oncogenes is unknown. To address this, we have studied NUP98-HOXD13-transgenic (NHD13-Tg) mice, which overexpress HOXA transcription factors throughout haematopoiesis and develop both myelodysplastic syndrome (MDS) progressing to acute myeloid leukemia (AML) as well as T-ALL. We find that thymocytes from preleukemic NHD13-Tg mice can serially transplant, demonstrating that they have self-renewal capacity. Transcriptome analysis shows that NHD13-Tg thymocytes exhibit a stem cell-like transcriptional program closely resembling that induced by Lmo2, including Lmo2 itself and its critical cofactor Lyl1. To determine whether Lmo2/Lyl1 are required for NHD13-induced thymocyte self-renewal, NHD13-Tg mice were crossed with Lyl1 knockout mice. This showed that Lyl1 is essential for expression of the stem cell-like gene expression program in thymocytes and self-renewal. Surprisingly however, NHD13 transgenic mice lacking Lyl1 showed accelerated T-ALL and absence of transformation to AML, associated with a loss of multipotent progenitors in the bone marrow. Thus, multiple T-cell oncogenes induce thymocyte self-renewal via Lmo2/Lyl1, however NHD13 can also promote T-ALL via an alternative pathway.